109 related articles for article (PubMed ID: 2279584)
1. Active suppression of the proliferative response to interleukin-2 in tumour-bearing mice.
Zajícová A; Holán V
Folia Biol (Praha); 1990; 36(6):301-11. PubMed ID: 2279584
[TBL] [Abstract][Full Text] [Related]
2. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia.
Gelin J; Andersson C; Lundholm K
Cancer Res; 1991 Feb; 51(3):880-5. PubMed ID: 1988128
[TBL] [Abstract][Full Text] [Related]
3. Tumour-bearing animals synthesize a decreased level of mRNA for the inducible 55,000 MW interleukin-2 receptor.
Holán V; Lipoldová M
Immunology; 1990 Apr; 69(4):626-8. PubMed ID: 2335381
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
[TBL] [Abstract][Full Text] [Related]
5. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
7. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.
Mellow L; Sabbadini E
Immunology; 1985 Oct; 56(2):235-43. PubMed ID: 2932383
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression in viral oncogenesis. III. Effects of virus infection on interleukin 1 and interleukin 2 generation and responsiveness.
Strayer DS; Horowitz M; Leibowitz JL
J Immunol; 1986 Dec; 137(11):3632-8. PubMed ID: 3023485
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
Sakurai T; Yamada M; Simamura S; Motoyoshi K
Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 production by immunologically hyporeactive tumour-bearing mice.
Holán V; Lipoldová M
Br J Cancer; 1990 May; 61(5):667-70. PubMed ID: 2337505
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IL-2-dependent proliferation by a prostaglandin-dependent suppressor factor.
Ferreri NR; Herzog WR; Askenase PW
J Immunol; 1993 Mar; 150(6):2102-11. PubMed ID: 8450204
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR.
Brooks JC; Hoskin DW
Transplantation; 1994 Nov; 58(10):1096-103. PubMed ID: 7974716
[TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
14. Tumour metastasis in mice with reduced immune reactivity. IV. Restoration of relative resistance to metastasis formation in thymectomized sub-lethally irradiated mice by spleen cells.
Suurküla M; Boeryd B
Pathol Eur; 1975; 10(4):299-305. PubMed ID: 1208121
[TBL] [Abstract][Full Text] [Related]
15. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.
McIntosh JK; Jablons DM; Mulé JJ; Nordan RP; Rudikoff S; Lotze MT; Rosenberg SA
J Immunol; 1989 Jul; 143(1):162-7. PubMed ID: 2499626
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
Dussault I; Miller SC
Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of production and sorption of interleukin 2 by lymphoid cells during growth of transplanted sarcoma].
Kushko LIa; Semenova-Kobzar' RA; Iudin VM; Koval'chuk EV; Berezhnaia NM
Eksp Onkol; 1988; 10(1):34-7. PubMed ID: 3259499
[TBL] [Abstract][Full Text] [Related]
18. Studies on the immunological disturbance in murine schistosomiasis japonica from the viewpoint of the interleukin cascade reaction.
Yamashita T; Watanabe T; Sendo F
Immunology; 1987 Oct; 62(2):215-21. PubMed ID: 3119470
[TBL] [Abstract][Full Text] [Related]
19. Low responsiveness of spleen cells from tumour-bearing mice to recombinant interleukin-1 and interleukin-2. Impaired expression of interleukin-2 receptors.
Holán V; Lipoldová M
Int J Cancer; 1990 Apr; 45(4):798-800. PubMed ID: 2323854
[No Abstract] [Full Text] [Related]
20. In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells.
Shu S; Chou T; Rosenberg SA
J Immunol; 1986 May; 136(10):3891-8. PubMed ID: 3486223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
